United Therapeutics Corporation (UTHR)
NASDAQ·Healthcare·Biotechnology
$566.69
+0.03%
Mkt Cap $25.13B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $813.08M | $790.20M | -2.81% | $7.13 | $7.70 | +7.99% | — | — |
| Q4 2025 Oct 29, 2025 | $814.80M | $799.50M | -1.88% | $6.89 | $7.16 | +3.92% | — | — |
| Q3 2025 Jul 30, 2025 | $801.87M | $798.60M | -0.41% | $7.29 | $6.41 | -12.07% | — | — |
| Q2 2025 Apr 30, 2025 | $778.66M | $794.40M | +2.02% | $6.29 | $6.63 | +5.41% | — | — |
| Q1 2025 Feb 26, 2025 | $734.73M | $735.90M | +0.16% | $6.40 | $6.19 | -3.28% | — | — |
| Q4 2024 Oct 30, 2024 | $722.62M | $748.90M | +3.64% | $6.43 | $6.39 | -0.62% | — | — |
| Q3 2024 Jul 31, 2024 | $691.87M | $714.90M | +3.33% | $6.40 | $5.85 | -8.59% | — | — |
| Q2 2024 May 1, 2024 | $623.97M | $677.70M | +8.61% | $5.65 | $6.17 | +9.20% | — | — |
| Q1 2024 Feb 21, 2024 | $575.87M | $614.70M | +6.74% | $4.19 | $4.36 | +4.06% | — | — |
| Q4 2023 Nov 1, 2023 | $587.90M | $609.40M | +3.66% | $5.04 | $5.38 | +6.75% | — | — |
| Q3 2023 Aug 2, 2023 | $524.17M | $596.50M | +13.80% | $4.51 | $5.24 | +16.19% | — | — |
| Q2 2023 May 3, 2023 | $514.37M | $506.90M | -1.45% | $4.52 | $4.86 | +7.52% | — | — |
| Q1 2023 Feb 22, 2023 | $519.21M | $491.50M | -5.34% | $4.51 | $2.67 | -40.80% | — | — |
| Q4 2022 Nov 2, 2022 | $493.21M | $516.00M | +4.62% | $3.89 | $4.91 | +26.22% | — | — |
| Q3 2022 Aug 3, 2022 | $461.06M | $466.90M | +1.27% | $4.13 | $2.41 | -41.65% | — | — |
| Q2 2022 May 4, 2022 | $420.06M | $461.90M | +9.96% | $3.35 | $5.03 | +50.15% | — | — |
| Q1 2022 Feb 24, 2022 | $427.59M | $415.20M | -2.90% | $3.72 | $2.35 | -36.83% | — | — |
| Q4 2021 Nov 3, 2021 | $438.10M | $444.70M | +1.51% | $3.59 | $3.42 | -4.74% | — | — |
| Q3 2021 Aug 4, 2021 | $446.50M | $446.50M | +0.00% | $3.02 | $3.65 | +20.86% | — | — |
| Q2 2021 May 5, 2021 | $368.31M | $379.10M | +2.93% | $2.94 | $0.61 | -79.25% | — | — |